Gallego demands transparency in Trump's deal with Pfizer
NegativeU.S News

Senator Ruben Gallego is expressing serious concerns about the transparency of President Trump's recent deal with Pfizer regarding drug pricing. He has reached out to Pfizer's CEO, Albert Bourla, demanding clarity on how the 'most favored nation' pricing agreement will be implemented. This matters because transparency in pharmaceutical pricing is crucial for public trust and accountability, especially when it involves government negotiations that could impact healthcare costs for millions.
— Curated by the World Pulse Now AI Editorial System